 Connection
Michael Arnold to Doxorubicin
This is a "connection" page, showing publications Michael Arnold has written about Doxorubicin.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.075 |
|
|
|
-
Wang Y, Ronckers CM, van Leeuwen FE, Moskowitz CS, Leisenring W, Armstrong GT, de Vathaire F, Hudson MM, Kuehni CE, Arnold MA, Demoor-Goldschmidt C, Green DM, Henderson TO, Howell RM, Ehrhardt MJ, Neglia JP, Oeffinger KC, van der Pal HJH, Robison LL, Schaapveld M, Turcotte LM, Waespe N, Kremer LCM, Teepen JC. Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer. Nat Med. 2023 09; 29(9):2268-2277.
Score: 0.051
-
Tobin LA, Xie Y, Tsokos M, Chung SI, Merz AA, Arnold MA, Li G, Malech HL, Kwong KF. Pegylated siRNA-loaded calcium phosphate nanoparticle-driven amplification of cancer cell internalization in vivo. Biomaterials. 2013 Apr; 34(12):2980-90.
Score: 0.024
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|